Cardiac Manifestations in a Group of Romanian Patients with Gaucher Disease Type 1 (a Monocentric Study)

被引:2
|
作者
Lazea, Cecilia [1 ]
Bucerzan, Simona [1 ,2 ]
Al-Khzouz, Camelia [1 ,2 ]
Zimmermann, Anca [3 ]
Vesa, Stefan Cristian [4 ]
Nascu, Ioana [5 ]
Cret, Victoria [5 ]
Crisan, Mirela [5 ]
Asavoaie, Carmen [5 ]
Miclea, Diana [6 ]
Grigorescu-Sido, Paula [7 ]
机构
[1] Iuliu Hatieganu Univ Med & Pharm, Emergency Pediat Hosp, Mother & Child Dept, Pediat Discipline 1,Clin Pediat 1, Cluj Napoca 400370, Romania
[2] Iuliu Hatieganu Univ Med & Pharm, Emergency Pediat Hosp, Dept Genet Dis, Cluj Napoca 400370, Romania
[3] Univ Med Ctr, Dept Diabetol & Endocrinol, Clin & Polyclin Internal Med 1, Med Clin 2,Clin Worms, D-55131 Mainz, Germany
[4] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol Toxicol & Clin Pharmacol, Cluj Napoca 400012, Romania
[5] Emergency Pediat Hosp, Cluj Napoca 400370, Romania
[6] Iuliu Hatieganu Univ Med & Pharm Emergency Pedia, Dept Med Genet, Cluj Napoca 400012, Romania
[7] Iuliu Hatieganu Univ Med & Pharm, Fac Med, Cluj Napoca 400012, Romania
关键词
Gaucher disease; pulmonary hypertension; valvular heart disease; VENTRICULAR SYSTOLIC DYSFUNCTION; EXPERT CONSENSUS DOCUMENT; PULMONARY-ARTERY PRESSURE; EUROPEAN ASSOCIATION; ECHOCARDIOGRAPHIC-ASSESSMENT; MITRAL REGURGITATION; AMERICAN SOCIETY; RIGHT HEART; HYPERTENSION; CALCIFICATION;
D O I
10.3390/diagnostics11060989
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gaucher disease (GD), one of the most common lysosomal disorders, is characterised by clinical heterogeneity. Cardiac involvement is rare and refers to pulmonary hypertension (PH), valvular abnormalities and myocardial infiltrative damage. The aim of this study was to evaluate cardiac involvement in a group of Romanian GD patients. Phenotypic and genotypic characterisation was carried out in 69 patients with GD type 1. Annual echocardiography and electrocardiography were performed to assess pulmonary pressure, morphology and function of the valves and electrocardiographic changes. Nine patients (13%) exhibited baseline echocardiographic signs suggesting PH. Mitral regurgitation was present in 33 patients (48%) and aortic regurgitation in 11 patients (16%). One patient presented aortic stenosis. Significant valvular dysfunction was diagnosed in 10% of patients. PH was associated with greater age (p < 0.001), longer time since splenectomy (p = 0.045) and longer time between clinical onset and the start of enzyme replacing therapy (p < 0.001). Electrocardiographic changes were present in five patients (7%).
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Dynamic changes of lipid profile in Romanian patients with Gaucher disease type 1 under enzyme replacement therapy: a prospective study
    Zimmermann, Anca
    Grigorescu-Sido, Paula
    Rossmann, Heidi
    Lackner, Karl J.
    Drugan, Cristina
    Al Khzouz, Camelia
    Bucerzan, Simona
    Nascu, Ioana
    Zimmermann, Tim
    Leucuta, Daniel
    Weber, Matthias M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (03) : 555 - 563
  • [22] Spontaneous regression of disease manifestations can occur in type 1 Gaucher disease; results of a retrospective cohort study
    Boomsma, Jooske M. F.
    van Dussen, Laura
    Wiersma, Maaike G.
    Groener, Johanna E. M.
    Aerts, Johannes M. F. G.
    Maas, Mario
    Hollak, Carla E. M.
    BLOOD CELLS MOLECULES AND DISEASES, 2010, 44 (03) : 181 - 187
  • [23] Neurological manifestations of type 1 Gaucher's disease:: is a revision of disease classification needed?
    Cherin, P.
    Sedel, F.
    Mignot, C.
    Schupbach, M.
    Gourfinkel-An, I.
    Verny, M.
    Baumann, N.
    REVUE NEUROLOGIQUE, 2006, 162 (11) : 1076 - 1083
  • [24] Hematologic malignancies and monoclonal gammopathy of undetermined significance in Gaucher disease type 1 patients in the International Collaborative Gaucher Group Gaucher Registry
    Rosenbloom, Barry
    Cappellini, Maria D.
    Dragosky, Marta
    Weinreb, Neal J.
    McClain, Monica R.
    Sekulic, Davorka
    Mistry, Pramod K.
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S91 - S92
  • [25] Neurological manifestations in Gaucher disease patients and relatives
    Giraldo, Pilar
    Alfonso, Pilar
    Latre, Paz
    Pocovi, Miguel
    BLOOD, 2007, 110 (11) : 27B - 28B
  • [26] The Evaluation of Skeletal Manifestations in Patients with Gaucher Disease
    Kasapkara, Cigdem Seher
    Olgac, Asburce
    Okur, Ilyas
    Ezgu, Fatih Suheyl
    Tumer, Leyla
    JOURNAL OF PEDIATRIC RESEARCH, 2021, 8 (03) : 257 - 261
  • [27] Neurological manifestations in patients with Gaucher disease and their relatives
    Giraldo, P.
    Alfonso, P.
    Latre, P.
    Pocovi, M.
    ACTA PAEDIATRICA, 2008, 97 : 118 - 118
  • [28] Neurological manifestations in patients with Gaucher disease and in their relatives
    Giraldo, Pilar
    Luis Capablo, Jose
    Alfonso, Pilar
    Latre, Paz
    Garcia, Beatriz
    Pocovi, Miguel
    MEDICINA CLINICA, 2008, 131 (05): : 175 - 179
  • [29] Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease
    Hollak, CEM
    Corssmit, EPM
    Aerts, JMFG
    Endert, E
    Sauerwein, HP
    Romijn, JA
    vanOers, MHJ
    AMERICAN JOURNAL OF MEDICINE, 1997, 103 (03): : 185 - 191
  • [30] Prevalence of autoantibodies in the course of Gaucher disease type 1: A multicenter study comparing Gaucher disease patients to healthy subjects
    Serratrice, Christine
    Bensalah, Nesma
    Penaranda, Guillaume
    Bardin, Nathalie
    Belmatoug, Nadia
    Masseau, Agathe
    Rose, Christian
    Lidove, Olivier
    Camou, Fabrice
    Maillot, Francois
    Leguy, Vanessa
    Magy-Bertrand, Nadine
    Marie, Isabelle
    Cherin, Patrick
    Bengherbia, Monia
    Carballo, Sebastian
    Boucraut, Jose
    Serratrice, Jacques
    Berger, Marc
    Verrot, Denis
    JOINT BONE SPINE, 2018, 85 (01) : 65 - 71